ITPA Genotypes Predict Anemia but Do Not Affect Virological Response with Interferon-Free Faldaprevir, Deleobuvir, and Ribavirin for HCV Infection-Reference-Cited by-同舟云学术

ITPA Genotypes Predict Anemia but Do Not Affect Virological Response with Interferon-Free Faldaprevir, Deleobuvir, and Ribavirin for HCV Infection

Published:2015-12-09 Issue:12 Volume:10 Page:e0144004
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Asselah Tarik,Zeuzem Stefan,Soriano Vicente,Bronowicki Jean-Pierre,Lohse Ansgar W.,Müllhaupt Beat,Schuchmann Marcus,Bourlière Marc,Buti Maria,Roberts Stuart K.,Gane Edward J.,Stern Jerry O.,Voss Florian,Baum Patrick,Gallivan John-Paul,Böcher Wulf O.,Mensa Federico J.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference28 articles.

1. Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection;JG McHutchison;N Engl J Med,2009

2. Telaprevir for previously untreated chronic hepatitis C infection;IM Jacobson;N Engl J Med,2011

3. Boceprevir for untreated chronic HCV genotype 1 infection;F Poordad;N Engl J Med,2011

4. Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C;EJ Gane;N Engl J Med,2013

5. ABT-450/r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis;F Poordad;N Engl J Med,2014

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tolerability of Erythrocyte Ribavirin Triphosphate Concentrations Depends on the ITPA Genotype;Therapeutic Drug Monitoring;2019-08

2. Ochre Resources, Behavioural Complexity and Regional Patterns in the Howiesons Poort;Journal of African Archaeology;2017-12-07

3. Is Ribavirin Teratogenic in Humans? No Evidence So Far;Drug Safety;2017-09-14

4. ITPA gene polymorphism (94C>A) effects on ribavirin-induced anemia during therapy in Egyptian patients with chronic hepatitis C;Journal of Medical Virology;2017-05-29

5. Impact of ITPA gene polymorphisms on the risk of ribavirin-induced haemolytic anaemia using interferon-free antivirals for chronic hepatitis C;Antiviral therapy;2017